• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/02/2016
Event Type  malfunction  
Event Description
On 02 november 2016, leica biosystems received a complaint that: "the tissue in both retorts, especially the biopsy tissue is fried." the complainant advised that some of the tissue samples involved were diagnosable without further action while other tissue samples needed to be re-cut after soaking.On 04 november 2016, leica biosystems received information that all tissue samples exhibiting sub-optimal tissue processing were diagnosable.Investigation of this complaint by leica biosystems is in progress.
 
Manufacturer Narrative
On (b)(6) 2016, leica biosystems received a complaint that: "the tissue in both retorts, especially the biopsy tissue is fried." the complainant advised a leica field support specialist (fss) that sub-optimal tissue processing had been identified for a period of three (3) weeks prior to initiation of this complaint; some of the tissue samples involved were diagnosable without further action, while other tissue samples needed to be re-cut after soaking and the affected tissue samples were described as "over-processed".The complainant also expressed concern that the reagent in bottle 9, which had been replaced on (b)(6) 2016 and diluted to 70%, had a concentration of 56% when measured with a hydrometer following completion of two (2) processing runs.On (b)(6) 2016, a fss attended the laboratory in order to obtain further details of the circumstances involved in this complaint and to provide applications support.The fss documented the presence of a large amount of salt crystals, a fatty substance and "sludge" in a number of reagent bottles; the absence of a gasket from bottles 5 and 16 and that the variance between the measured and calculated ethanol concentration in bottles 4, 6 and 9 exceeded the acceptable limit.The fss emptied, cleaned and then replaced the reagent in all bottles.Investigation of this complaint found that the instrument functioned as designed between (b)(6) 2016, which is the period that sub-optimal tissue processing was reported by the complainant.The root cause of the sub-optimal tissue processing reported is considered likely to be a combination of use errors.Specifically, failure to follow the manufacturer instructions detailed in the leica peloris/peloris ll user manual in relation to cleaning and maintenance of the reagent bottles as evidenced by the presence significant amounts of foreign material contaminating several bottles; and failure to follow the manufacturer instructions detailed in the leica peloris/peloris ll user manual in relation completion of the manual reagent replacement process.These use errors may impact the accuracy of the reagent concentration calculated by the instrument software.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, victoria 3149
AS   3149
92117535
MDR Report Key6137334
MDR Text Key61501298
Report Number8020030-2016-00082
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/30/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberPELORIS
Device Catalogue Number26.0005
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/02/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/15/2007
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-